Reassessing Synopsys (SNPS) After Recent Pullback And NVIDIA’s US$2.0b Investment

• If you are wondering whether Synopsys at around US$414 a share still makes sense for your portfolio, starting with a clear view of what you are paying for is essential.
• The stock is currently below recent levels, with a 5.9% decline over the last 7 days, 11.0% over 30 days, a 13.8% decline year to date and a 9.5% decline over 1 year, while the 3 year and 5 year returns sit at 12.7% and 81.7% respectively.
• These moves have put valuation back in focus for many investors, especially given Synopsys' role in software tools that sit at the heart of chip design and automation. Recent coverage has highlighted how investors are reassessing what they are willing to pay for high quality software names, which feeds directly into how Synopsys is priced today.
• On our checks, Synopsys currently scores 2 out of 6 on our valuation framework. This means it screens as undervalued on 2 of the 6 metrics we use, as shown in its valuation score. In the sections that follow we will walk through the main approaches to valuing the stock before finishing with a way to assess valuation that goes beyond any single metric.

Synopsys scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Synopsys Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of the cash a company may generate in the future and discounts those amounts back to today to arrive at an estimate of what the business could be worth now.

For Synopsys, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month Free Cash Flow is about $2.24b. Analysts provide explicit forecasts out to 2030, with Simply Wall St extrapolating beyond the first few years to create a full 10 year path of Free Cash Flow, reaching a projected $5.30b in 2030 and continuing with additional estimates through 2035.

When these projected cash flows are discounted back to today, the model points to an estimated intrinsic value of about $458.42 per share. Compared with the recent share price of around $414, the DCF output implies the stock is 9.7% undervalued, which is a relatively small gap.

Result: ABOUT RIGHT

Synopsys is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Synopsys.

Approach 2: Synopsys Price vs Earnings

For a profitable company like Synopsys, the P/E ratio is a useful way to think about what you are paying for each dollar of current earnings. It also conveniently reflects what the market is baking in for future growth and risk, since investors usually accept a higher P/E when they expect stronger growth or see the earnings stream as relatively resilient.

Synopsys currently trades on a P/E of about 71.7x. That sits well above the broader Software industry average of 26.4x and also above the peer group average of 40.6x. To give more context, Simply Wall St calculates a proprietary “Fair Ratio” for Synopsys of 43.3x, which represents the P/E you might expect given its earnings growth profile, industry, profit margins, size and identified risks.

This Fair Ratio is more tailored than a simple peer or industry comparison because it adjusts for company specific factors rather than assuming all software names deserve the same multiple. When set against the current P/E of 71.7x, the 43.3x Fair Ratio indicates that Synopsys is trading at a richer level than this model would suggest.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Synopsys Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, a simple way for you to write the story you see for Synopsys, link that story to your own revenue, earnings and margin estimates, and then arrive at a fair value you can directly compare to the current share price.

On Simply Wall St’s Community page, Narratives let you connect what you believe about Synopsys, such as how the Ansys integration, AI driven demand or 2026 transition risks may play out, to a set of financial forecasts that roll up into a fair value estimate. That fair value can then help you decide whether today’s price of around US$414 looks attractive, stretched, or somewhere in between for your specific case.

Narratives are refreshed when new information comes through. For example, updates to analyst targets between about US$550 and US$715, earnings releases, guidance changes or news like NVIDIA’s US$2.0b investment at US$414.79 per share are incorporated, so your story and implied fair value stay aligned with the latest data rather than being a one off calculation.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com